Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs
Study Details
Study Description
Brief Summary
Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The primary aim of this study is to compare the success rates of ONB techniques performed with ultrasound guided or blind technique. Its secondary purpose is to compare the effect of peroperative bleeding and control cystoscopy performed in the postoperative 3rd month on the presence of recurrent tumor.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Ultrasound-guided obturator nerve block group The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. |
Procedure: obturator nerve block
The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. The time elapsed until the first needle insertion and local anesthetic injection is completed will be recorded as the application time.
|
Active Comparator: obtutaror nerve block with anatomical landmarks In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. |
Procedure: obturator nerve block
The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. The time elapsed until the first needle insertion and local anesthetic injection is completed will be recorded as the application time.
|
Outcome Measures
Primary Outcome Measures
- Preoperative succesful obturator nerve block [operation time]
peroperative adductor muscle spazm
Secondary Outcome Measures
- peroperative bleeding, Presence of recurrent tumor at postoperative 3rd month [3 months]
peroperative bledding, Control by cystoscopy in the postoperative 3rd month recurrence tumor size
Eligibility Criteria
Criteria
Inclusion Criteria:
- ASA I-II patients
Exclusion Criteria:
-
Tumors that disrupt the integrity of the bladder,
-
bladder floor tumors,
-
coagulation disorders,
-
motor in the lower limbs
-
with sensory disturbances,
-
uncooperative patients,
-
Known allergy to local anesthetics
-
patients with localized infection at the procedure site
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mugla Sitki Kocman University | Mugla | Turkey | 48000 |
Sponsors and Collaborators
- Muğla Sıtkı Koçman University
Investigators
- Principal Investigator: Eylem Yaşar, Muğla Sıtkı Koçman University
- Study Chair: Ali İhsan Uysal, Mugla Sitki Kocman University Department of Anesthesia
- Study Chair: İlker Akarken, Mugla Sitki Kocman University Department of Urology
- Study Chair: basak altiparmak, Mugla Sitki Kocman University Department of Anesthesia
- Study Chair: semra demirbilek, Mugla Sitki Kocman University Department of Anesthesia
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 27/12/2019-19/VIII